Corporate partners
Warner Chilcott is a leading U.S. specialty pharmaceutical company specializing in the areas of dermatology and women's healthcare. Based in Rockaway, N.J., the company develops, manufactures and markets branded prescription pharmaceutical products, including Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment and Dovonex® (calcipotriene, 0.005%) Cream for the topical treatment of psoriasis, Dovonex® (calcipotriene, 0.005%) Scalp Solution for scalp psoriasis and an oral antibiotic named Doryx® (doxycycline hyclate) Delayed-Release Tablets, 75 mg and 100 mg for the treatment of acne and other bacterial infections. For more information, please visit Warner Chilcott's Web site at www.warnerchilcott.com.
The link above takes you off the Psoriasis Foundation Web site. The Psoriasis Foundation does not endorse or accept any responsibility for the content of external Web sites. Click here for complete terms of use.
|
